Dror Oranit, Shulman-Peleg Alexandra, Nussinov Ruth, Wolfson Haim J
School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Curr Med Chem. 2004 Jan;11(1):71-90. doi: 10.2174/0929867043456287.
A major goal in contemporary drug design is to develop new ligands with high affinity of binding toward a given protein receptor. Pharmacophore, which is the three-dimensional arrangement of essential features that enable a molecule to exert a particular biological effect, is a very useful model for achieving this goal. If the three dimensional structure of the receptor is known, pharmacophore is a complementary tool to standard techniques, such as docking. However, frequently the structure of the receptor protein is unknown and only a set of ligands together with their measured binding affinities towards the receptor is available. In such a case, a pharmacophore based strategy is one of the few applicable tools. Here we present a broad, yet concise guide to pharmacophore identification and review a sample of applications for drug design. In particular, we present the framework of the algorithms, classify their modules and point out their advantages and challenges.
当代药物设计的一个主要目标是开发对特定蛋白质受体具有高结合亲和力的新配体。药效团是使分子能够发挥特定生物学效应的基本特征的三维排列,是实现这一目标的非常有用的模型。如果受体的三维结构已知,药效团是对接等标准技术的补充工具。然而,受体蛋白的结构通常是未知的,只有一组配体及其对受体的测量结合亲和力可用。在这种情况下,基于药效团的策略是少数适用的工具之一。在这里,我们提供了一份广泛而简洁的药效团识别指南,并回顾了药物设计的一些应用示例。特别是,我们介绍了算法的框架,对其模块进行了分类,并指出了它们的优点和挑战。